EUCTR2005-003081-42-GB进行中（未招募）1 期
EXPLORING THE THERAPEUTIC POTENTIAL OF XANTHINE OXIDASE INHIBITORS IN CORONARY ARTERY DISEASE - allopurinol in CAD
niversity of DUndee0 个研究点目标入组 124 人开始时间: 2005年7月25日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 124
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •1) Stable angina pectoris with no heart failure
- •2) Acute MI
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Renal failure. Creatinine > 190mM/l
- •Contraindication to allopurinol (as per BNF)
研究者
相似试验
已完成
不适用
Exploring the therapeutic potential of xanthine oxidase inhibitor allopurinol in anginaISRCTN15253766niversity of Dundee (UK)88
尚未招募
不适用
Treatment of Oral Submucous Fibrosis with Xanthinol Nicotinate, Dexamethasone and Levamisole.CTRI/2019/05/019008Dr Shaikh Saba Sultana
进行中（未招募）
1 期
Allopurinol, brain lesions, heart size and blood pressure after ischaemic strokeEUCTR2013-004235-77-GBHS Greater Glasgow & Clyde464
已完成
不适用
Do Xanthine Oxidase Inhibitors (XOI) have clinically useful anti-ischaemic effects in the treatment of angina pectoris? A double-blind, placebo controlled trialCoronary Artery Disease - patients with chronic stable anginaCirculatory SystemCoronary Artery DiseaseISRCTN82040078niversity of Dundee (UK)60
招募中
3 期
Investigating the effect of quince oxymel on non-alcoholic fatty liveron-alcoholic fatty liver.Fatty (change of) liver, not elsewhere classifiedK76.0IRCT20221202056689N1Ghoum University of Medical Sciences80